Saturday, March 29, 2025
Home Tags David Hoey

Tag: David Hoey

Vaxxas hits enrollment target in trial of HD-MAP technology for pandemic response

Australian biotechnology company Vaxxas has completed enrollment for its largest clinical trial to date, testing the safety and immune response of its high-density microarray patch (HD-MAP) for vaccine delivery. 

Vaxxas secures $2M grant from BARDA to develop needle-free mRNA vaccines

Vaxxas, a clinical-stage biotechnology company specializing in high-density microarray patch (HD-MAP) vaccine delivery, has been awarded a $2 million (AUD 3.2 million) grant as a Concept Stage winner in the United States Biomedical Advanced Research and Development Authority’s (BARDA) $50 million Patch Forward Prize. 

Vaxxas to develop first room-temperature stable RSV vaccine with NIH license

Vaxxas, a clinical-stage biotechnology company known for its innovative high-density microarray patch (HD-MAP) vaccination platform, has secured a worldwide license from the United States National Institutes of Health (NIH) for a next-generation vaccine antigen aimed at combating Respiratory Syncytial Virus (RSV). 

Vaxxas’ new needle-free vaccine manufacturing plant opens in Queensland

Biotechnology company Vaxxas has completed work on its new needle-free vaccine technology manufacturing facility in Northshore Hamilton. 

Vaxxas’ needle-free seasonal influenza vaccine enters clinical trial

Vaxxas has commenced the Phase I clinical trial of the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate via its proprietary high-density microarray patch (HD-MAP) technology.

Vaxxas kickstarts needle-free COVID-19 vaccine clinical trial

Australian biotechnology company Vaxxas has begun the Phase I clinical trial of the first needle-free COVID-19 vaccine candidate. 
Advertisement

Golden Beach Fencing

Com2 Communications

Power Machinery Australia

Featured Article

Circular beds: Revolutionising sustainable bedding in Australia

A new wave of innovation is transforming the Australian manufacturing sector, with sustainability at its core. ROBOVOID, in collaboration with Swinburne University, GT Recycling, and Sustainability Victoria, has developed a groundbreaking bed base made entirely from recycled plastic.